FWD, Roche partnership targets early diagnostics

The partnership will run for three years.

FWD Group has partnered with Roche Diagnostics Asia Pacific to deliver cost-effective health solutions that improve patient outcomes by utilising advanced diagnostic technologies.

The three-year cooperation agreement aims to improve early diagnosis, leading to better health outcomes and potentially life-saving decisions. The agreement will be rolled out progressively across selected FWD markets in the coming months.

Binayak Dutta, Managing Director of FWD Group, emphasised the shift from reactive to proactive healthcare as critical to enhancing customer well-being.

Dr. Sarah Salvilla, FWD’s Group Chief Health Officer, highlighted Roche’s expertise in diagnostics, which delivered 29 billion tests globally last year, as key to accelerating innovation in health insurance across Asia.